Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation

Figure 1 Survival probabilities for the first 5 yr after treatment. Overall HCC patient survival who had received TACE and OLT, only TACE and patients who received no treatment.

Figure 2 Kaplan-Meier patient survival curves showing survival dependent on UICC stage.

Figure 3 Kaplan-Meier patient survival curves demonstrating that OLT improved survival UICC stageIand II.

Figure 4 Kaplan-Meier patient survival curves. OLT improved survival UICC stage III.

Figure 5 Kaplan-Meier patient survival curves. OLT improved survival UICC stage IV.

Figure 6 Survival probabilities for the first 5 years after liver transplantation according to the Milan criteria (A) and tumor size (B).